Skip to main content
Euglena Co., Ltd. logo

Euglena Co., Ltd. — Investor Relations & Filings

Ticker · 2931 ISIN · JP3944370000 LEI · 529900OW9QKWU8LU7D52 T Manufacturing
Open in API
Filings indexed 78 across all filing types
Latest filing 2024-01-10 M&A Activity
Country JP Japan
Listing T 2931

About Euglena Co., Ltd.

https://www.euglena.jp/en/

Euglena Co., Ltd. is a biotechnology company that pioneered the world's first successful outdoor mass cultivation of the edible microalgae, Euglena. The company's core activities are centered on a "Sustainability First" philosophy. Its Healthcare business develops and markets food and cosmetic products that utilize the 59 rich nutrients found in Euglena to support well-being. The Biofuel business focuses on the research, development, and production of next-generation sustainable fuels derived from sources including microalgae and used cooking oil. The company also actively enters new fields to promote social change and contribute to a sustainable society.

Recent filings

Filing Released Lang Actions
臨時報告書
M&A Activity Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report) and is submitted to the Kanto Local Finance Bureau Director on January 10, 2024. The primary content details the resolution and execution of a stock exchange agreement (株式交換) where Euglena Co., Ltd. (the filer) becomes the parent company acquiring two subsidiaries (Satys Pharmaceutical and Nihon Viewtech). This type of disclosure, mandated by Japanese financial regulations (specifically mentioning Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act and related Cabinet Office Ordinance), concerns a significant corporate action (M&A/Capital Structure change) that requires immediate reporting outside of regular periodic filings (like 10-K or IR). In the provided classification scheme, this event—a major transaction involving the acquisition of other companies—best fits under 'Capital/Financing Update' (CAP) if it were a financing round, or 'M&A Activity' (TAR) if it were a merger/takeover. Since this is a stock exchange for acquisition, TAR (Merger/Takeover Activity) is the most appropriate fit, as stock exchanges are a form of business combination/acquisition. It is not a standard 10-K, AR, ER, or IR. It is a specific regulatory filing about a transaction, not just an announcement of a report (RPA/RNS).
2024-01-10 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically related to the accuracy of the 3rd Quarter Report (第３四半期報告書). While it references the quarterly report, it is a standalone regulatory filing confirming the validity of the financial statements. Since it does not fit into the specific categories for full reports or announcements, it falls under the general regulatory filing category.
2023-11-13 Japanese
四半期報告書－第19期第3四半期(2023/07/01－2023/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Euglena Co., Ltd. covering the third quarter of the 19th fiscal year (period from July 1, 2023, to September 30, 2023). It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as management analysis. This fits the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-11-13 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act, specifically related to the accuracy of the Second Quarter Report (第２四半期報告書). While it references a quarterly report, the document itself is a standalone regulatory filing confirming the accuracy of the financial statements, which is a standard regulatory requirement in Japan. Since it is a specific regulatory filing that does not constitute the full quarterly report itself, it falls under the RNS category.
2023-08-14 Japanese
四半期報告書－第19期第2四半期(2023/04/01－2023/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Euglena Co., Ltd. covering the second quarter of the 19th fiscal year (April 1, 2023, to June 30, 2023). It includes detailed financial statements, management analysis (MDA), and regulatory disclosures required under the Financial Instruments and Exchange Act of Japan. As it contains comprehensive financial data for an interim period, it is classified as an Interim/Quarterly Report. Q2 2023
2023-08-14 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の４の８第１項' (Article 24-4-8, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of a quarterly report, rather than being the quarterly report itself. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS). Q1 2023
2023-05-12 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.